A Research Use Only statement does not necessarily settle classification where the wider presentation promotes personal use, recovery, injury treatment, inflammation control or another medicinal purpose
doi:10.1016/j.jmoldx.2010.10.004 Preuss CV, Wood TC, Szumlanski CL, et al
Large trials point to real GLP-1 heart benefits and GLP-1 kidney benefits : fewer heart attacks and strokes, and slower kidney damage in selected patients with type 2 diabetes or high cardiovascular risk
182 Escherichia coli can cause gastrointestinal infections and other local tissue/organ infections under certain conditions
Some people may also experience a placebo effect, feeling an immediate improvement simply because they expect to
Plasma glucose responses to glucose, sucrose, and honey in patients with diabetes mellitus: an analysis of glycaemic and peak incremental indices